Nav: Home

Folic acid reduces risk of neural tube defects linked to HIV drug dolutegravir

July 23, 2019

Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving the drug during early gestation. Researchers at Baylor College of Medicine suspected that folic acid (vitamin B9), which is known to prevent the vast majority of neural tube defect cases, could be a part of the puzzle of dolutegravir's negative side effects.

The body transforms dietary folic acid into folate, which mediates normal neural tube development. The researchers discovered that the drug interferes with the binding of folate to its receptor, thus promoting neural tube defects. Importantly, folic acid supplementation can mitigate the risk of the medication in an animal model, suggesting that having folic acid-fortified foods available to the population at risk would significantly reduce the chance of dolutegravir triggering this type of neurodevelopmental problems. The study appears in the journal AIDS.

"Neural tube defects occur when the development of the neural tube, the embryonic central nervous system that gives rise to the brain and spinal cord, is disrupted during early stages of embryonic development. In humans, this refers to gestational days 17 to 30," said first and corresponding author Dr. Robert Cabrera, associate professor in the Center for Precision Environmental Health and the Department of Molecular and Cellular Biology at Baylor College of Medicine.

Thanks to a number of clinical research studies conducted during the past 50 years, researchers know that dietary folic acid has a protective effect against the vast majority of neural tube defects. This finding led to the implementation of mandatory folic acid fortification of grains and cereal products in 87 countries, including the U.S. since 1999, and consequently to the prevention of the vast majority of neural tube defect cases in these countries.

The body requires folic acid to conduct a number of cellular processes, including the synthesis of the building blocks of DNA, which is essential for proliferating cells. Lacking enough folic acid inhibits DNA synthesis and cell proliferation and can have serious consequences, especially in the growing embryo, which is engaged in active cell proliferation. Folic acid deficiency in the embryo, together with genetic and environmental factors, can result in failed closure of the neural tube and lead to defects.

"My colleagues and I have experience studying folate and its interaction with its receptor, which mediates folate effects, so we decided to investigate whether the association between dolutegravir and higher risk of neural tube defects involved folate receptor interactions with folate," Cabrera said.

Previous evidence has indicated that interfering with the folate receptor can lead to neural tube defects. Studies in laboratory animals have shown that this disruption can result in developmental defects in the offspring. In addition, Cabrera and his colleagues had previously found that the levels of antibodies to folate receptor are higher in serum of mothers with babies with neural tube defects.

Using a variety of laboratory techniques, the researchers discovered in this study that at therapeutic concentrations the drug does disrupt the binding of folate to its receptor. This disruption involves at least four players: folate, folate receptor, dolutegravir and calcium ions. It is known that calcium increases folate binding to its receptor and that doluteglavir has affinity for positively charged ions such as calcium. The researchers propose that dolutegravir alters folate receptor binding by interacting with calcium, and the resultant complex is less soluble and less available to carry its biological functions.

Furthermore, working with the zebrafish animal model, Cabrera and his colleagues also discovered that exposing embryos to dolutegravir starting one to three hours after fertilization completely disrupted embryo development; but, importantly, this toxicity was mitigated by simultaneously providing folate to the embryos. Interestingly, exposing embryos to the drug five to eight hours after fertilization did not alter their development, indicating that early development is the critical period in which embryos are most susceptible to doluteglavir toxicity.

In populations that have folic acid-fortified foods available, women of childbearing age have a reduced risk of having babies with neural tube defects. For instance, the Centers for Disease Control and Prevention report that in the U.S. less than 1 percent of the population is deficient in folic acid. But in other countries such as Botswana that do not have this type of fortified foods, up to 40 percent of the people can be deficient in folate, Cabrera explained.

"In Botswana, up to one-third of the women are HIV-positive and this medication is being used mainly by women of childbearing age. Considering that these same women probably also are deficient in folate and other vitamins and minerals and may have anemia caused by iron deficiency, the combined effect with the medication increases the chance of neural tube defects on their babies," Cabrera said. "It's like the perfect storm, but the good news is that there is an easy solution that several countries have already implemented - provide foods fortified with folic acid."
This work underscores the importance of considering the dietary conditions of individual populations when introducing new medications, as drug interactions with individuals and their offspring may be different depending on the nutritional status of the population.

Other contributors to this work include Jaclyn P. Souder (at Baylor College of Medicine and University of Alabama at Birmingham), John W. Steele, Lythou Yeo, Gabriel Tukeman, Daniel A. Gorelick and Richard H. Finnell, all at Baylor College of Medicine.

Financial support for this work was provided by the National Institute of Child Health and Human Development (R01HD081216-05 and P01HD067244), the National Institute of General Medical Sciences (T32GM008361) and the National Institute of Environmental Health Sciences (T32ES027801).

Baylor College of Medicine

Related Folic Acid Articles:

Hypertensive patients may benefit from folic acid supplements
Hypertensive adults with low platelet count who took a combined daily pill of both enalapril and folic acid saw a 73 percent reduction in their risk of first stroke compared to patients who took only enalapril daily, according to a study published in the Journal of the American College of Cardiology.
Formate prevents most folic acid-resistant neural tube defects in mice
A multi-institutional research team has developed a novel folic acid-resistant neural tube defect mouse model of the human condition by silencing the Slc25a32 gene, and, in most of the mutant mice, neural tube defects can be prevented by formate supplementation.
Folic acid late in pregnancy may increase childhood allergy risk
Research from the University of Adelaide suggests that taking folic acid in late pregnancy may increase the risk of allergies in children affected by growth restriction during pregnancy.
Folic acid may mitigate autism risk from pesticides
Researchers at UC Davis and other institutions have shown that mothers who take recommended amounts of folic acid around conception might reduce their children's pesticide-related autism risk.
Psychological benefits for kids when mums keep taking folic acid
Taking folic acid supplements throughout pregnancy may improve psychological development in children.
Folic acid supplementation recommended for prevention of neural tube defects
The US Preventive Services Task Force recommends that all women who are planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400-800 μg) of folic acid.
Daily folic acid supplementation remains important for prevention of birth defects
Despite the mandatory addition of folic acid to enriched grain products in the United States, many women still do not consume adequate amounts of this important vitamin, according to an editorial written by Laura E.
Folic acid fortified food linked to decline in congenital heart defects
Food fortified with folic acid helped lower overall rates of congenital heart defects in Canada.
Less decline than expected in brain, spine defects after folic acid fortification program
There is less decline than expected in the rate of brain and spine defects after a folic acid fortification program, a Stanford study finds.
Putting the spotlight on folic acid supplementation in pregnancy
Future Science Group today announced the publication of a new article in Future Science OA, reviewing national and international guidelines for folic acid supplementation, and analyzing its potential risks and benefits in terms of maternal and fetal outcomes.
More Folic Acid News and Folic Acid Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#541 Wayfinding
These days when we want to know where we are or how to get where we want to go, most of us will pull out a smart phone with a built-in GPS and map app. Some of us old timers might still use an old school paper map from time to time. But we didn't always used to lean so heavily on maps and technology, and in some remote places of the world some people still navigate and wayfind their way without the aid of these tools... and in some cases do better without them. This week, host Rachelle Saunders...
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at